Neuroprotective properties of resveratrol in different neurodegenerative disorders

Diego Albani, Letizia Polito, Alessandra Signorini, Gianluigi Forloni

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

The natural phytocompound resveratrol has been considered for many years a potential anticancer drug, but recently it has come to the attention of neuroscientist too, as it displays neuroprotective actions and activates the sirtuins' family member SIRT1. Sirtuins are enzymes with preferential deacetylase activity. Human sirtuins are coded by seven genes (SIRT1-7). The most investigated sirtuin is SIRT1, which is involved in several physiologic and pathologic processes including apoptosis, autophagy, diabetes, cancer, cardiovascular disorders, and neurodegeneration. Resveratrol has neuroprotective features both in vitro and in vivo in models of Alzheimer's disease (AD), but it has proved to be beneficial also in ischemic stroke, Parkinson's disease, Huntington's disease, and epilepsy. Here, we summarize the in vitro and in vivo experimental results highlighting the possible role of resveratrol as neuroprotective biofactor with a particular focus on AD.

Original languageEnglish
Pages (from-to)370-376
Number of pages7
JournalBioFactors
Volume36
Issue number5
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Sirtuins
Neurodegenerative Diseases
Alzheimer Disease
Huntington Disease
Autophagy
Pathologic Processes
Parkinson Disease
Epilepsy
Medical problems
Stroke
Apoptosis
Genes
Enzymes
Pharmaceutical Preparations
resveratrol
Neoplasms
In Vitro Techniques

Keywords

  • Alzheimer's disease
  • Neuroprotection
  • Resveratrol
  • Review
  • SIRT1

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Neuroprotective properties of resveratrol in different neurodegenerative disorders. / Albani, Diego; Polito, Letizia; Signorini, Alessandra; Forloni, Gianluigi.

In: BioFactors, Vol. 36, No. 5, 09.2010, p. 370-376.

Research output: Contribution to journalArticle

Albani, Diego ; Polito, Letizia ; Signorini, Alessandra ; Forloni, Gianluigi. / Neuroprotective properties of resveratrol in different neurodegenerative disorders. In: BioFactors. 2010 ; Vol. 36, No. 5. pp. 370-376.
@article{07a7431849c34c4eaf6282a2c4a54e6b,
title = "Neuroprotective properties of resveratrol in different neurodegenerative disorders",
abstract = "The natural phytocompound resveratrol has been considered for many years a potential anticancer drug, but recently it has come to the attention of neuroscientist too, as it displays neuroprotective actions and activates the sirtuins' family member SIRT1. Sirtuins are enzymes with preferential deacetylase activity. Human sirtuins are coded by seven genes (SIRT1-7). The most investigated sirtuin is SIRT1, which is involved in several physiologic and pathologic processes including apoptosis, autophagy, diabetes, cancer, cardiovascular disorders, and neurodegeneration. Resveratrol has neuroprotective features both in vitro and in vivo in models of Alzheimer's disease (AD), but it has proved to be beneficial also in ischemic stroke, Parkinson's disease, Huntington's disease, and epilepsy. Here, we summarize the in vitro and in vivo experimental results highlighting the possible role of resveratrol as neuroprotective biofactor with a particular focus on AD.",
keywords = "Alzheimer's disease, Neuroprotection, Resveratrol, Review, SIRT1",
author = "Diego Albani and Letizia Polito and Alessandra Signorini and Gianluigi Forloni",
year = "2010",
month = "9",
doi = "10.1002/biof.118",
language = "English",
volume = "36",
pages = "370--376",
journal = "BioFactors",
issn = "0951-6433",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Neuroprotective properties of resveratrol in different neurodegenerative disorders

AU - Albani, Diego

AU - Polito, Letizia

AU - Signorini, Alessandra

AU - Forloni, Gianluigi

PY - 2010/9

Y1 - 2010/9

N2 - The natural phytocompound resveratrol has been considered for many years a potential anticancer drug, but recently it has come to the attention of neuroscientist too, as it displays neuroprotective actions and activates the sirtuins' family member SIRT1. Sirtuins are enzymes with preferential deacetylase activity. Human sirtuins are coded by seven genes (SIRT1-7). The most investigated sirtuin is SIRT1, which is involved in several physiologic and pathologic processes including apoptosis, autophagy, diabetes, cancer, cardiovascular disorders, and neurodegeneration. Resveratrol has neuroprotective features both in vitro and in vivo in models of Alzheimer's disease (AD), but it has proved to be beneficial also in ischemic stroke, Parkinson's disease, Huntington's disease, and epilepsy. Here, we summarize the in vitro and in vivo experimental results highlighting the possible role of resveratrol as neuroprotective biofactor with a particular focus on AD.

AB - The natural phytocompound resveratrol has been considered for many years a potential anticancer drug, but recently it has come to the attention of neuroscientist too, as it displays neuroprotective actions and activates the sirtuins' family member SIRT1. Sirtuins are enzymes with preferential deacetylase activity. Human sirtuins are coded by seven genes (SIRT1-7). The most investigated sirtuin is SIRT1, which is involved in several physiologic and pathologic processes including apoptosis, autophagy, diabetes, cancer, cardiovascular disorders, and neurodegeneration. Resveratrol has neuroprotective features both in vitro and in vivo in models of Alzheimer's disease (AD), but it has proved to be beneficial also in ischemic stroke, Parkinson's disease, Huntington's disease, and epilepsy. Here, we summarize the in vitro and in vivo experimental results highlighting the possible role of resveratrol as neuroprotective biofactor with a particular focus on AD.

KW - Alzheimer's disease

KW - Neuroprotection

KW - Resveratrol

KW - Review

KW - SIRT1

UR - http://www.scopus.com/inward/record.url?scp=78650902065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650902065&partnerID=8YFLogxK

U2 - 10.1002/biof.118

DO - 10.1002/biof.118

M3 - Article

C2 - 20848560

AN - SCOPUS:78650902065

VL - 36

SP - 370

EP - 376

JO - BioFactors

JF - BioFactors

SN - 0951-6433

IS - 5

ER -